Night Shift Work and Cancer Risk: How IARC Graded the Evidence

A Group 2A label from the International Agency for Research on Cancer (IARC) tells you how confident scientists are that something can cause cancer, not how much it raises your odds. When IARC classified night shift work as "probably carcinogenic to humans" in 2019, it was answering a narrow question about the weight of the evidence, and reading it as a personal risk number is the single most common mistake people make with it.

Key points#

• IARC grades the strength of evidence that an agent can cause cancer, not the magnitude of anyone's risk.
• Group 2A ("probably carcinogenic") reflects a specific mix: limited evidence in humans, sufficient evidence in animals, and strong mechanistic data.
• For night shift work, the human cancer evidence is graded "limited," meaning credible but not able to rule out chance, bias, or confounding.
• A hazard grade carries no dose, no threshold, and no individual risk estimate, so it cannot by itself settle a personal decision.

The one distinction that explains everything: hazard versus risk#

Start with the split that most headlines miss. A hazard evaluation asks a yes-or-no question: is this agent capable of causing cancer at all, under some conditions? A risk assessment asks a how-much question: given a real level and duration of contact, how likely is cancer? IARC answers only the first. It sorts agents by how well the evidence supports the hazard claim, then leaves the magnitude of risk to other bodies and to context.

A quick analogy makes the point. Fire safety inspectors can certify that a material is flammable without telling you the odds that your specific building will burn down. Flammability is a property of the material; the odds depend on how much of it there is, how it is stored, and whether anyone lights a match. IARC certifies the "flammability." It does not run the fire model for your life.

This is why Group 2A is such a mixed list. It includes red meat, glyphosate, and emissions from high-temperature frying alongside night shift work. Sharing a tier does not mean sharing a risk magnitude, because the tiers were never designed to rank magnitude in the first place.

Reading the IARC scale#

IARC uses four groupings that describe confidence in the evidence:

• Group 1, carcinogenic to humans (the evidence is convincing).
• Group 2A, probably carcinogenic.
• Group 2B, possibly carcinogenic.
• Group 3, not classifiable.

Under IARC's framework, a 2A classification generally rests on at least two lines of evidence, with at least one anchored in humans or human tissue. The usual route is limited evidence in people combined with sufficient evidence in experimental animals, or strong mechanistic evidence pointing to a cancer-causing pathway that also operates in humans.

How night shift work reached 2A#

In June 2019 a Working Group of 27 scientists from 16 countries met at IARC in Lyon to re-examine the topic. Their conclusion, published in The Lancet Oncology as "Carcinogenicity of night shift work" and in Monographs Volume 124, was that the combined evidence justified Group 2A. Three strands carried different weights.

The animal evidence did the heavy lifting#

"Sufficient evidence in experimental animals" is a defined threshold, reached when well-conducted studies establish a causal relationship between an agent and cancer. Rodent experiments involving light during the biological night and other forms of circadian disruption produced increased tumors, and that body of work cleared the bar.

The mechanism was biologically coherent#

IARC also asks whether an agent shows the recognized key characteristics of carcinogens. Disruption of the circadian clock, altered melatonin signaling, and dysregulation of core clock genes are plausible routes to cancer, touching cell proliferation, DNA repair, immune surveillance, and metabolism. The mechanistic evidence was judged strong.

The human evidence stopped short#

This is where the grade settled below Group 1. In IARC's vocabulary, "limited evidence" is precise: a positive association was seen and is credible, but chance, bias, or confounding could not be ruled out with reasonable confidence. Epidemiological studies have linked night work to breast, prostate, and colorectal cancer, yet the findings are inconsistent, and several large cohorts did not confirm the breast cancer signal.

Why the human data are so hard to pin down#

A few recurring problems keep the human evidence at "limited" rather than "sufficient":

• No common definition. Studies label "night shift work" in very different ways, from ever having worked nights to detailed reconstructions of lifetime schedules, which makes results hard to pool.
• Confounding is stubborn. People who work nights differ from day workers in sleep, diet, body weight, and socioeconomic circumstances, and untangling the schedule from everything that travels with it is difficult.
• Recall is imperfect. Many case-control studies ask people to reconstruct decades of work history from memory.

The Working Group specifically flagged this variability in how the work was measured as a central limitation. It is a large part of why the human strand stayed at "limited."

Worth noting: this was a re-evaluation, not a fresh alarm. IARC had already placed shift work involving circadian disruption in Group 2A back in 2007. The 2019 review folded in more than a decade of newer studies and, after weighing them, kept the same grade under the sharper label of "night shift work."

What the classification deliberately leaves out#

A Group 2A label carries no dose, no threshold, and no individual risk estimate. It does not say how many years of night work, or how many nights per month, would matter, or by how much any one person's odds change. It does not separate an occasional overnight from decades of rotating shifts, and it does not identify who is most susceptible. Because it is a hazard identification, it cannot on its own justify a specific personal decision. Those judgments belong to risk assessment, which weighs real-world levels, competing risks, and the reality that essential around-the-clock work in medicine, transport, and public safety cannot simply be switched off.

The honest reading is narrow and useful. The evidence that night shift work can contribute to cancer is strong enough in animals and mechanism, and suggestive enough in humans, to sit in the "probably" tier while the epidemiology keeps maturing. Better measurement of the work itself and more prospective cohorts are what would push the grade up or down. Treating a hazard grade as a settled measure of personal danger reads more certainty into it than the science supports.